Speaker: Abhinav Agarwal
Clinical Case Presentation
(NICU)
Presenting features:
 Early Preterm (33 wk) weighing 1900g
 Appropriate for gestational age
 Born to G2P1L1 mother by emergency LSCS for
meconium stained amniotic fluid
 Vigorous at birth
 Did not receive delivery room resuscitation
 Admitted for NNH at 96 hr without any
incompatibility
 No H/O any antenatal drug intake except iron
and folate
 On further interrogation - elder sibling, 1.5-year
old, also have ambiguous genitalia
Examination at birth
 Stable vitals
 Genital examination:
 Underdeveloped
scrotum
 Median raphe +
 Bilateral gonads not
palpable
 Penile length = 4 mm
 Hypospadias +
 No
hyperpigmentation
 Rest systemic
examination normal
Plan
 In view of above observations -
Virilized female
 Congenital adrenal hyperplasia
 Rule out virilizing maternal
conditions
Undermasculanised male
 Androgen insensitivity
 5 alpha reductase deficiency
 Testosterone biosynthesis defects
Investigations:
Date 1/2/16 4/2/16 7/2/16
Day of life 3 h 64 h Day 6
Dextrose 65 82 88
17- OHP 9.53 (normal)
Serum cortisol 14.4 (normal)
Karyotyping Awaited
Hb 14.9
TC 23,900
DC N75 L16 E5
Platelet 3.63 lac
Urea 57
Creatinine 0.7
Sodium 136
Potassium 4.5
USG abdomen Bilateral testis + in superficial inguinal ring, no mullerian
structures present, ? adrenals appear bulky.
 Elder sibling Index case
Approach to baby with ambiguous
genitalia
 When to suspect –
 Micropenis: Stretched penile length <2.5cm in a term
newborn
 Asymmetry of labioscrotal folds
 B/L cryptorchidism
 U/L cryptorchidism with hypospadias
 B/L testes with perineoscrotal or penoscrotal
hypospadias
 Female external genitalia with clitoromegaly (> 1 cm) or
inguinal hernia
 Overtly abnormal genitals like cloacal exstrophy
History
1) Family history- CAH, hypospadias, cryptorchidism,
infertility, pubertal delay, consanguinity
2) Neonatal death- male sibling from vomiting or
dehydration (CAH)
3) Maternal drug exposure- androgens, antiandrogens
(finasteride, spironolactone), estrogens, progestins,
phenytoin
4) Maternal virilization during pregnancy- virilizing
adrenal or ovarian tumor, placental aromatase
Examination
1) External genitalia-
• Stretched penile length <2.5 cm in term infant -
microphallus
clitoris >1cm length, >0.6 cm diameter -
clitoromegaly
• Presence of chordee
• position of urethral meatus
• presence of vaginal opening
• pigmentation and symmetry of scrotum or labioscrotal
folds
• Anogenital ratio- distance between anus and posterior
2). Gonadal size, position and descent- should be
carefully noted
• palpable gonad below inguinal ligament usually a
testis
• an ovotestis or uterus may present as inguinal hernia
3). Associated anomalies- other dysmorphic features
suggesting Denys-Drash syndrome, WAGR syndrome
etc.
Sex determination and
differentiation
Hormone biosynthesis pathway
Investigations
 Serum electrolytes
 Blood sugar
 Hormonal study (17-OHP and testosterone – 1st line) after 72 hrs
of life
 Karyotyping- using FISH for SRY region
 Ultrasonography-
• to see mullerian structure
• to visualize testis and its position
• to visualize adrenal glands (CAH)
• to see associated malformations in kidneys, ureter, bladder
 Genitogram
 MRI- when USG is indeterminate
 Exploratory laparotomy/ Laparoscopy
Endocrinal Evaluation
Hypothalamic/pituitary/gonadal Axis:
• Gonadotropins: LH, FSH
• Gonadal response: Testosterone, DHT, estrogen
Adrenal function:
• Electrolytes, 17-OH-P
• DHEAS
• Cortisol
Response to challenges:
• GnRH stimulation
• HCG stimulation
Discussion:
 Disorders of sex development (DSD)/ Intersex -
congenital conditions in which development of chromosomal,
gonadal, or anatomical sex is atypical
 Old terminology- New terminology (4
types)
- 46, XX DSD
- psuedohermaphroditism - 46, XY DSD
- true hermaphroditism - Sex chromosome
DSD
-Syndromes with
ambiguous
genitalia
Types of DSD
1). 46,XX virilized female
 Congenital adrenal hyperplasia
 21-hydroxylase deficiency,
 11-hydroxylase deficiency
 3 beta hydroxysteroid
dehydrogenase deficiency
 Aromatase deficiency(fetal and
maternal)
 Virilizing maternal conditions
 CAH
 Adrenal/ovarian tumors
 Drugs-progestin, androgen
2). 46,XY undervirilized male
 Disorders of testis development-
-LH receptor mutation
-Vanishing testis (gestational loss of testis)
 Defects in androgen synthesis
- 17β HSD defect
- 3β HSD defect
- 17,20 lyase defect
 Defects in testosterone metabolism
- 5 α reductase type 2 deficiency
 End organ resistance-
- Androgen insensitivity syndrome (AIS)
-Partial
-Complete
3). Gonadal differentiation and
chromosomal disorders
 Ovotesticular DSD (true
hermaphroditism)
 Mixed gonadal dysgenesis (45X,
46XY)
 Complete gonadal dysgenesis
(46,XY)
 46,XX testicular DSD
4). Syndromes with
ambiguous genitalia
 Campomelic dysplasia
 Denys-Drash syndrome
 Frasier syndrome
 WAGR syndrome
 Robinow syndrome
Algorithm for evaluation of 46,XX DSD
Uterus present
17 Hydroxy progesterone
Increased
Normal Normal
Ovotestis on USG
Biopsy:
Ovarian folicles &
testicular tubules
Ovotesticular DSD
(true hermaphroditism)
CAH
Maternal virilization/
Exogenous androgen exposure
Maternal virilizing disorders:
Medications: Progestins
Tumors (adrenal/ovarian)
Luteomas of pregnancy
Aromatase deficiency
MotherBaby
Uterus absent
46 XX Testicular DSD
Algorithm for evaluation of 46,XY DSD
Karyotype 46 XY
No uterus
USG pelvis
Uterus present
hCG stimulation test
Gonadal biopsy:
•Persistent mullerian duct
syndrome
T & DHT:
AIS (Ar mutation
analysis)/
Idiopathic
Normal T & DHT
: 5 alpha reductase
deficiency
T and DHT:
LH/FSH : gonadal dysgenesis,
leydig cell hypoplasia
Precursor steroids : T-biosynthesis
defect
hCG stimulation test
 Evaluation of gonadal axis in children
 Assess testosterone secretion by testes
 500 IU of hCG given i/m daily for 3 days or
5000U/m2 single dose
 Serum testosterone, DHT, DHEA, androstenedione,
LH & FSH are measured at baseline and then 24 hr
after last dose or after 72 hr if single dose was given
 Collection of 24 hr urine before & after three doses
of hCG to detect precursors to detect testosterone
biosynthesis defect
Interpretation
 2 to 20 times rise in testosterone i.e rise > 0.8 ng/ml
or absolute levels > 0.9 ng/ml
1)adequate rise indicates presence of functioning
testes
2)if rise is blunted –enzymatic defect in testosterone
synthesis, gestational loss of testicular tissue
(vanishing testis syndrome), LH receptor mutation
3) ↑ T:DHT ratio(>20:1)- 5 alpha reductase deficiency
4) T: A ratio (<0.8:1) – 17β- HSD deficiency
5) Raised LH,FSH denotes anorchia or primary
gonadal failure
6) Increased precursor steroid denotes biosynthesis
Evaluation of Elder Sibling
Date Age Features
21/5/14 Birth Ambiguous Genitalia +
24/7/14 2 month Bifid scrotum, hypospadias, Small penis, Anus +,
LH = 0.91 (0.02-0.3)
FSH = 15.24 (0.16 – 4.1)
DHEA = 119.3 (31.6 - 214)
28/7/14 2 month USG: Small soft elongatd homogenous structure with no
specific morphology in bilateral inguinal region (? Small
undescended testis) Right- 11 x 4.5 mm Left- 10 x 4.9 mm
Cortisol = 1.2 mcg/dl (5 – 48) Testosterone = 0.03 ng/dl
(75 - 400)
19/8/14 2.5 month 5 alpha reductase = 2.5 ng/dl (prepubertal <3 ng/dl)
25/8/14 3 month hCG stimulation test = poor response (testosterone=16.31
ng/dl)
MRI abdomen: bilateral undesended testis in inguinal area +
2/9/14 3.5 month Karyotype = XY
21/5/15 12 month MCU = male type urethra with Normal MCU study
8/2/16 19 month LH = 1.19 mIU/ml (0.02-0.3)
Testosterone = <10 ng/dl (75 - 400)
hCG stimulation test = poor response
Final Diagnosis
 Disorders of testis development-
-LH receptor mutation
Defects in androgen synthesis
- 17β HSD defect
- 3β HSD defect
- 17,20 lyase defect
Gonadal dysgenesis
Management:
 General guidelines:
Try to match the baby’s sex assignment to the
chromosomal and gonadal sex if possible
Try to anticipate pubertal development
Consider future function when planning surgeries
Try to preserve fertility
Respect the opinions of well-informed parents
Treatment options include :
 Reconstructive surgery
 Hormone therapy
Incidence in India:
Etiology and clinical profile of ambiguous genitalia studied (n=109)
1) Genetic females with virilisation or FPH –27.5 %(n=30)
Congenital adrenal hyperplasia (CAH) was the underlying cause in all
cases of FPH
Salt wasting form - 23/30
Simple virilising form – 7/30
2) Genetic males undervirilised or MPH –52.3 %(n=57)
Androgen insensitivity syndrome - 28% (16/57)
5- alpha reductase deficiency - 23%(13/57) .
3) Disorder of gonadal differentiation- 10.1%(n=11)
Gonadal dysgenesis – 9/11
True hermaphrodite – 2/11
4) Syndromic form of ambiguous genitalia- 1.8% (n=2)
(Rajesh R. Joshi, Sudha Rao, Meena Desai. Etiology and clinical profile of ambiguous genitalia-an
overview of 10 years experience. Indian Pediatrics, 2006;43:974-979.)
Prognosis in subsequent
pregnancies:
46, XX DSD
CAH – 25%
46, XY DSD –
Complete Gonadal Dysgenesis - Low
Androgen Insensitivity Syndrome – Low
Hormone Biosynthetic Pathway – 25%
Sex chromosome DSD - low
Syndromes with ambiguous genitalia – according
to syndrome
(David Amor. Genetic Counselling. In: Disorders of Sex
Development: An Integrated Approach to Management. Eds. John M.
Hutson, Garry L. Warne, Sonia R. Grover. Springer, Berlin, Germany,
2012: pp 202-213)
 Sarah
Gronert (born 6
July 1986) is a
retired German
tennis player.
She won a total
of ten titles on
the ITF circuit in
her career and
her best world
ranking of 164
came on 14 May
2012
Not end of life:
 Tony Briffa
 Has Partial Androgen
Insensitivity Syndrome.
 Independent councillor,
mayor and deputy mayor in
the City of Hobsons Bay,
Victoria.
 Briffa is considered the
world's first
openly intersex mayor and
public office-bearer
 Tony Briffa was raised as a
girl, and lived as a woman
until he was 30.
 Briffa is one of the first
people to be public about a
Ambiguous Genitalia

Ambiguous Genitalia

  • 1.
    Speaker: Abhinav Agarwal ClinicalCase Presentation (NICU)
  • 2.
    Presenting features:  EarlyPreterm (33 wk) weighing 1900g  Appropriate for gestational age  Born to G2P1L1 mother by emergency LSCS for meconium stained amniotic fluid  Vigorous at birth  Did not receive delivery room resuscitation  Admitted for NNH at 96 hr without any incompatibility  No H/O any antenatal drug intake except iron and folate  On further interrogation - elder sibling, 1.5-year old, also have ambiguous genitalia
  • 3.
    Examination at birth Stable vitals  Genital examination:  Underdeveloped scrotum  Median raphe +  Bilateral gonads not palpable  Penile length = 4 mm  Hypospadias +  No hyperpigmentation  Rest systemic examination normal
  • 4.
    Plan  In viewof above observations - Virilized female  Congenital adrenal hyperplasia  Rule out virilizing maternal conditions Undermasculanised male  Androgen insensitivity  5 alpha reductase deficiency  Testosterone biosynthesis defects
  • 5.
    Investigations: Date 1/2/16 4/2/167/2/16 Day of life 3 h 64 h Day 6 Dextrose 65 82 88 17- OHP 9.53 (normal) Serum cortisol 14.4 (normal) Karyotyping Awaited Hb 14.9 TC 23,900 DC N75 L16 E5 Platelet 3.63 lac Urea 57 Creatinine 0.7 Sodium 136 Potassium 4.5 USG abdomen Bilateral testis + in superficial inguinal ring, no mullerian structures present, ? adrenals appear bulky.
  • 6.
  • 7.
    Approach to babywith ambiguous genitalia  When to suspect –  Micropenis: Stretched penile length <2.5cm in a term newborn  Asymmetry of labioscrotal folds  B/L cryptorchidism  U/L cryptorchidism with hypospadias  B/L testes with perineoscrotal or penoscrotal hypospadias  Female external genitalia with clitoromegaly (> 1 cm) or inguinal hernia  Overtly abnormal genitals like cloacal exstrophy
  • 8.
    History 1) Family history-CAH, hypospadias, cryptorchidism, infertility, pubertal delay, consanguinity 2) Neonatal death- male sibling from vomiting or dehydration (CAH) 3) Maternal drug exposure- androgens, antiandrogens (finasteride, spironolactone), estrogens, progestins, phenytoin 4) Maternal virilization during pregnancy- virilizing adrenal or ovarian tumor, placental aromatase
  • 9.
    Examination 1) External genitalia- •Stretched penile length <2.5 cm in term infant - microphallus clitoris >1cm length, >0.6 cm diameter - clitoromegaly • Presence of chordee • position of urethral meatus • presence of vaginal opening • pigmentation and symmetry of scrotum or labioscrotal folds • Anogenital ratio- distance between anus and posterior
  • 10.
    2). Gonadal size,position and descent- should be carefully noted • palpable gonad below inguinal ligament usually a testis • an ovotestis or uterus may present as inguinal hernia 3). Associated anomalies- other dysmorphic features suggesting Denys-Drash syndrome, WAGR syndrome etc.
  • 11.
  • 12.
  • 13.
    Investigations  Serum electrolytes Blood sugar  Hormonal study (17-OHP and testosterone – 1st line) after 72 hrs of life  Karyotyping- using FISH for SRY region  Ultrasonography- • to see mullerian structure • to visualize testis and its position • to visualize adrenal glands (CAH) • to see associated malformations in kidneys, ureter, bladder  Genitogram  MRI- when USG is indeterminate  Exploratory laparotomy/ Laparoscopy
  • 14.
    Endocrinal Evaluation Hypothalamic/pituitary/gonadal Axis: •Gonadotropins: LH, FSH • Gonadal response: Testosterone, DHT, estrogen Adrenal function: • Electrolytes, 17-OH-P • DHEAS • Cortisol Response to challenges: • GnRH stimulation • HCG stimulation
  • 15.
    Discussion:  Disorders ofsex development (DSD)/ Intersex - congenital conditions in which development of chromosomal, gonadal, or anatomical sex is atypical  Old terminology- New terminology (4 types) - 46, XX DSD - psuedohermaphroditism - 46, XY DSD - true hermaphroditism - Sex chromosome DSD -Syndromes with ambiguous genitalia
  • 16.
    Types of DSD 1).46,XX virilized female  Congenital adrenal hyperplasia  21-hydroxylase deficiency,  11-hydroxylase deficiency  3 beta hydroxysteroid dehydrogenase deficiency  Aromatase deficiency(fetal and maternal)  Virilizing maternal conditions  CAH  Adrenal/ovarian tumors  Drugs-progestin, androgen 2). 46,XY undervirilized male  Disorders of testis development- -LH receptor mutation -Vanishing testis (gestational loss of testis)  Defects in androgen synthesis - 17β HSD defect - 3β HSD defect - 17,20 lyase defect  Defects in testosterone metabolism - 5 α reductase type 2 deficiency  End organ resistance- - Androgen insensitivity syndrome (AIS) -Partial -Complete
  • 17.
    3). Gonadal differentiationand chromosomal disorders  Ovotesticular DSD (true hermaphroditism)  Mixed gonadal dysgenesis (45X, 46XY)  Complete gonadal dysgenesis (46,XY)  46,XX testicular DSD 4). Syndromes with ambiguous genitalia  Campomelic dysplasia  Denys-Drash syndrome  Frasier syndrome  WAGR syndrome  Robinow syndrome
  • 18.
    Algorithm for evaluationof 46,XX DSD Uterus present 17 Hydroxy progesterone Increased Normal Normal Ovotestis on USG Biopsy: Ovarian folicles & testicular tubules Ovotesticular DSD (true hermaphroditism) CAH Maternal virilization/ Exogenous androgen exposure Maternal virilizing disorders: Medications: Progestins Tumors (adrenal/ovarian) Luteomas of pregnancy Aromatase deficiency MotherBaby Uterus absent 46 XX Testicular DSD
  • 19.
    Algorithm for evaluationof 46,XY DSD Karyotype 46 XY No uterus USG pelvis Uterus present hCG stimulation test Gonadal biopsy: •Persistent mullerian duct syndrome T & DHT: AIS (Ar mutation analysis)/ Idiopathic Normal T & DHT : 5 alpha reductase deficiency T and DHT: LH/FSH : gonadal dysgenesis, leydig cell hypoplasia Precursor steroids : T-biosynthesis defect
  • 20.
    hCG stimulation test Evaluation of gonadal axis in children  Assess testosterone secretion by testes  500 IU of hCG given i/m daily for 3 days or 5000U/m2 single dose  Serum testosterone, DHT, DHEA, androstenedione, LH & FSH are measured at baseline and then 24 hr after last dose or after 72 hr if single dose was given  Collection of 24 hr urine before & after three doses of hCG to detect precursors to detect testosterone biosynthesis defect
  • 21.
    Interpretation  2 to20 times rise in testosterone i.e rise > 0.8 ng/ml or absolute levels > 0.9 ng/ml 1)adequate rise indicates presence of functioning testes 2)if rise is blunted –enzymatic defect in testosterone synthesis, gestational loss of testicular tissue (vanishing testis syndrome), LH receptor mutation 3) ↑ T:DHT ratio(>20:1)- 5 alpha reductase deficiency 4) T: A ratio (<0.8:1) – 17β- HSD deficiency 5) Raised LH,FSH denotes anorchia or primary gonadal failure 6) Increased precursor steroid denotes biosynthesis
  • 22.
    Evaluation of ElderSibling Date Age Features 21/5/14 Birth Ambiguous Genitalia + 24/7/14 2 month Bifid scrotum, hypospadias, Small penis, Anus +, LH = 0.91 (0.02-0.3) FSH = 15.24 (0.16 – 4.1) DHEA = 119.3 (31.6 - 214) 28/7/14 2 month USG: Small soft elongatd homogenous structure with no specific morphology in bilateral inguinal region (? Small undescended testis) Right- 11 x 4.5 mm Left- 10 x 4.9 mm Cortisol = 1.2 mcg/dl (5 – 48) Testosterone = 0.03 ng/dl (75 - 400) 19/8/14 2.5 month 5 alpha reductase = 2.5 ng/dl (prepubertal <3 ng/dl) 25/8/14 3 month hCG stimulation test = poor response (testosterone=16.31 ng/dl) MRI abdomen: bilateral undesended testis in inguinal area + 2/9/14 3.5 month Karyotype = XY 21/5/15 12 month MCU = male type urethra with Normal MCU study 8/2/16 19 month LH = 1.19 mIU/ml (0.02-0.3) Testosterone = <10 ng/dl (75 - 400) hCG stimulation test = poor response
  • 23.
    Final Diagnosis  Disordersof testis development- -LH receptor mutation Defects in androgen synthesis - 17β HSD defect - 3β HSD defect - 17,20 lyase defect Gonadal dysgenesis
  • 24.
    Management:  General guidelines: Tryto match the baby’s sex assignment to the chromosomal and gonadal sex if possible Try to anticipate pubertal development Consider future function when planning surgeries Try to preserve fertility Respect the opinions of well-informed parents Treatment options include :  Reconstructive surgery  Hormone therapy
  • 25.
    Incidence in India: Etiologyand clinical profile of ambiguous genitalia studied (n=109) 1) Genetic females with virilisation or FPH –27.5 %(n=30) Congenital adrenal hyperplasia (CAH) was the underlying cause in all cases of FPH Salt wasting form - 23/30 Simple virilising form – 7/30 2) Genetic males undervirilised or MPH –52.3 %(n=57) Androgen insensitivity syndrome - 28% (16/57) 5- alpha reductase deficiency - 23%(13/57) . 3) Disorder of gonadal differentiation- 10.1%(n=11) Gonadal dysgenesis – 9/11 True hermaphrodite – 2/11 4) Syndromic form of ambiguous genitalia- 1.8% (n=2) (Rajesh R. Joshi, Sudha Rao, Meena Desai. Etiology and clinical profile of ambiguous genitalia-an overview of 10 years experience. Indian Pediatrics, 2006;43:974-979.)
  • 26.
    Prognosis in subsequent pregnancies: 46,XX DSD CAH – 25% 46, XY DSD – Complete Gonadal Dysgenesis - Low Androgen Insensitivity Syndrome – Low Hormone Biosynthetic Pathway – 25% Sex chromosome DSD - low Syndromes with ambiguous genitalia – according to syndrome (David Amor. Genetic Counselling. In: Disorders of Sex Development: An Integrated Approach to Management. Eds. John M. Hutson, Garry L. Warne, Sonia R. Grover. Springer, Berlin, Germany, 2012: pp 202-213)
  • 27.
     Sarah Gronert (born6 July 1986) is a retired German tennis player. She won a total of ten titles on the ITF circuit in her career and her best world ranking of 164 came on 14 May 2012 Not end of life:
  • 28.
     Tony Briffa Has Partial Androgen Insensitivity Syndrome.  Independent councillor, mayor and deputy mayor in the City of Hobsons Bay, Victoria.  Briffa is considered the world's first openly intersex mayor and public office-bearer  Tony Briffa was raised as a girl, and lived as a woman until he was 30.  Briffa is one of the first people to be public about a